Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.

[1]  E. Nicastri,et al.  Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox , 2023, Journal of medical virology.

[2]  S. Duhan,et al.  Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA , 2023, Emerging infectious diseases.

[3]  E. Nicastri,et al.  Temporal intra‐host variability of mpox virus genomes in multiple body tissues , 2023, Journal of medical virology.

[4]  N. K. Shah,et al.  An Mpox-Related Death in the United States. , 2023, The New England journal of medicine.

[5]  Wooyoung Jang,et al.  Monkeypox in an immunocompromised patient with underlying human immunodeficiency virus and syphilis infections in Southern Florida of the United States: a case report , 2023, AIDS Research and Therapy.

[6]  E. Nicastri,et al.  Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection , 2023, iScience.

[7]  G. Cooke,et al.  Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection , 2023, The Lancet. Infectious diseases.

[8]  B. Clotet,et al.  Mpox in people with advanced HIV infection: a global case series , 2023, The Lancet.

[9]  T. Perl,et al.  Severe Mpox Infections in People with Uncontrolled Human Immunodeficiency Virus (HIV). , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  K. Smith,et al.  Progressively confluent monkeypox lesions with necrosis , 2023, Oxford medical case reports.

[11]  Z. Liu,et al.  The land-scape of immune response to monkeypox virus , 2022, EBioMedicine.

[12]  B. Clotet,et al.  Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain , 2022, The Lancet. Infectious diseases.

[13]  A. Henao-Martínez,et al.  Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort , 2022, AIDS.

[14]  F. Nolent,et al.  Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations , 2022, Nature Microbiology.

[15]  D. Ene,et al.  First [18F]-FDG-PET/CT images of a patient infected with Monkeypox , 2022, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  C. Agrati,et al.  Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study , 2022, The Lancet. Infectious diseases.

[17]  O. Turriziani,et al.  Longitudinal Virological and Immunological Profile in a Case of Human Monkeypox Infection , 2022, Open forum infectious diseases.

[18]  A. Alcamí,et al.  Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study , 2022, The Lancet. Microbe.

[19]  Cameron R. Wolfe,et al.  Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[20]  M. Koopmans,et al.  Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals , 2022, Nature Medicine.

[21]  H. Asgeirsson,et al.  Ten-Week Follow-Up of Monkeypox Case-Patient, Sweden, 2022 , 2022, Emerging infectious diseases.

[22]  M. Beadsworth,et al.  Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study , 2022, The Lancet. Infectious diseases.

[23]  C. Pasquier,et al.  A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome , 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[24]  V. Calvez,et al.  Viral loads in clinical samples of men with monkeypox virus infection: a French case series , 2022, The Lancet. Infectious diseases.

[25]  Alexandre Braga de Miranda,et al.  Severe disseminated clinical presentation of monkeypox virus infection in an immunosuppressed patient: first death report in Brazil , 2022, Revista da Sociedade Brasileira de Medicina Tropical.

[26]  C. Boesecke,et al.  Severe monkeypox-virus infection in undiagnosed advanced HIV infection , 2022, Infection.

[27]  P. Ortiz-Romero,et al.  Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study , 2022, The Lancet.

[28]  A. Antinori,et al.  Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. , 2022, The New England journal of medicine.

[29]  J. Blanco,et al.  Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[30]  E. Nicastri,et al.  Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[31]  S. Rowland-Jones,et al.  Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV , 2021, Nature Communications.

[32]  D. Rebrikov,et al.  Constant companion: clinical and developmental aspects of torque teno virus infections , 2020, Archives of Virology.

[33]  C. Ihekweazu,et al.  Clinical course and outcome of human monkeypox in Nigeria. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  G. Pantaleo,et al.  T‐cell exhaustion in HIV infection , 2019, Immunological reviews.

[35]  Anna M. Mandra,et al.  Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report , 2019, The Lancet. Infectious diseases.

[36]  C. Scagnolari,et al.  Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients , 2018, Scientific Reports.

[37]  J. Muyembe,et al.  Maternal and Fetal Outcomes Among Pregnant Women With Human Monkeypox Infection in the Democratic Republic of Congo , 2017, The Journal of infectious diseases.

[38]  G. Antonelli,et al.  Torquetenovirus: the human virome from bench to bedside. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[39]  R. Wilkinson,et al.  Immune reconstitution inflammatory syndrome in HIV-infected patients , 2015, HIV/AIDS.

[40]  I. Krznaric,et al.  Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. , 2010, Virology.

[41]  G. Antonelli,et al.  Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[42]  F. Ennis,et al.  Immunological memory after exposure to variola virus, monkeypox virus, and vaccinia virus. , 2007, The Journal of infectious diseases.

[43]  Matthew A. Meier,et al.  Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  K. Ole,et al.  TTV Viral Load As a Marker for Immune Reconstitution After Initiation of HAART in HIV-Infected Patients , 2002 .